BeStock  
Stocks › Medical Devices › PRCT

PROCEPT BioRobotics PRCT

US equityMarket cap rank #3227Medical DevicesRobotics
$17.91 +$0.40 (+2.28%)
Pre-market · Oct 8, 9:00 am ET · After hours $17.91 0.00%
Open$17.63
Prev close$17.51
Day range$17.63 – $18.46
Volume1.15M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$94.50M+19.3% YoY
Operating profit-$27.39M-23.4% YoY
Net profit-$26.86M-37.2% YoY
Diluted EPS-$0.47-34.3% YoY
Free cash flow-$22.20M-24.4% YoY
Operating cash flow-$19.25M

Revenue, last 8 quarters

$58.4MSep '24$68.2MDec '24$69.2MMar '25$79.2MJun '25$83.3MSep '25$76.4MDec '25$83.1MMar '26$94.5MJun '26

Net profit, last 8 quarters

$-21.0MSep '24$-18.9MDec '24$-24.7MMar '25$-19.6MJun '25$-21.4MSep '25$-29.8MDec '25$-31.6MMar '26$-26.9MJun '26

Diluted EPS by quarter

-0.40Sep '24-0.35Dec '24-0.45Mar '25-0.35Jun '25-0.38Sep '25-0.53Dec '25-0.56Mar '26-0.47Jun '26

Free cash flow by quarter

$-19.0MSep '24$-33.6MDec '24$-18.8MMar '25$-17.8MJun '25$-9.5MSep '25$-12.2MDec '25$-41.0MMar '26$-22.2MJun '26

Annual revenue

$7.7MFY20$34.5MFY21$75.0MFY22$136.2MFY23$224.5MFY24$308.1MFY25

Profitability & balance sheet

Gross margin64.2%
Operating margin-33.9%
Net margin-32.5%
Return on equity-30.2%
Return on assets-22.1%
Return on invested capital-25.5%
Current ratio6.55
Liabilities / assets29.1%
Cash & investments$227.91M
Total debt$75.00M
Net cash (debt)$152.92M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $94.50M $83.13M $308.05M $76.38M $83.33M
Total Operating Revenue $94.50M $83.13M $308.05M $76.38M $83.33M
Cost of Revenue $32.12M $29.19M $111.83M $30.07M $29.32M
Gross Profit $62.38M $53.95M $196.23M $46.31M $54.01M
Operating Expense $89.77M $86.55M $300.09M $77.35M $77.20M
Selling and Admin Expenses $69.67M $65.09M $228.81M $58.30M $59.01M
Research & Development $20.10M $21.47M $71.28M $19.06M $18.19M
Operating Profit -$27.39M -$32.61M -$103.86M -$31.04M -$23.19M
Net Non-Operating Interest Income (Expense) $623,000.00 $925,000.00 $8.63M $1.54M $1.78M
Non-Operating Interest Income $1.47M $1.74M $12.22M $2.44M $2.70M
Non-Operating Interest Expense $842,000.00 $818,000.00 $3.59M $894,000.00 $919,000.00
Pretax Profit -$26.77M -$31.68M -$95.38M -$29.66M -$21.41M
Tax $94,000.00 -$43,000.00 $190,000.00 – –
Net Profit -$26.86M -$31.64M -$95.57M -$29.85M -$21.41M
Profit from Continuing Operations -$26.86M -$31.64M -$95.57M -$29.85M -$21.41M
Net Income to Parent Company -$26.86M -$31.64M -$95.57M -$29.85M -$21.41M
Net Income to Common Stockholders -$26.86M -$31.64M -$95.57M -$29.85M -$21.41M
Basic EPS -$0.47 -$0.56 -$1.72 -$0.53 -$0.38
Diluted EPS -$0.47 -$0.56 -$1.72 -$0.53 -$0.38
Other Income (Expense) – – -$156,000.00 – –
Other Non-Operating Income (Expenses) – – -$156,000.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $479.35M $487.06M $508.08M $508.08M $511.54M
Total Current Assets $420.29M $428.03M $450.38M $450.38M $454.75M
Cash and Cash Equivalents & Short-Term Investments $227.91M $245.64M $286.50M $286.50M $294.28M
-Cash and Cash Equivalents $227.91M $245.64M $286.50M $286.50M $294.28M
Receivables $107.61M $96.39M $83.53M $83.53M $84.50M
-Accounts Receivable $107.61M $96.39M $83.53M $83.53M $84.50M
Inventory $77.06M $77.54M $70.69M $70.69M $66.72M
Other Current Assets $7.70M $8.47M $9.65M $9.65M $9.25M
Total Non-Current Assets $59.07M $59.03M $57.70M $57.70M $56.79M
Net PPE $48.61M $48.90M $47.94M $47.94M $47.93M
-Gross PPE $64.94M $63.32M $60.69M $60.69M $60.12M
-Accumulated Depreciation -$16.34M -$14.42M -$12.75M -$12.75M -$12.20M
Goodwill and Other Intangible Assets $571,000.00 $640,000.00 $709,000.00 $709,000.00 $727,000.00
Other Non-Current Assets $9.89M $9.49M $9.06M $9.06M $8.14M
Total Liabilities $139.28M $139.40M $142.21M $142.21M $131.27M
Total Current Liabilities $64.20M $63.64M $65.80M $65.80M $53.90M
Payables $15.07M $18.85M $18.74M $18.74M $11.12M
-Accounts Payable $15.07M $18.85M $17.29M $17.29M $11.12M
Short-Term Debt and Capital Lease Obligation $2.51M $2.36M $2.21M $2.21M $2.14M
-Current Capital Lease Obligation $2.51M $2.36M $2.21M $2.21M $2.14M
Current Deferred Liabilities $14.09M $13.70M $13.05M $13.05M $10.67M
Other Current Liabilities $12.09M $10.25M $7.39M $7.39M $8.18M
Total Non-Current Liabilities $75.09M $75.76M $76.42M $76.42M $77.37M
Long Term Debt and Capital Lease Obligation $75.00M $75.64M $76.27M $76.27M $76.79M
-Long Term Debt $51.72M $51.66M $51.62M $51.62M $51.57M
-Long Term Capital Lease Obligation $23.28M $23.97M $24.65M $24.65M $25.23M
Other Non-Current Liabilities $91,000.00 $121,000.00 $147,000.00 $147,000.00 $576,000.00
Total Equity $340.07M $347.67M $365.87M $365.87M $380.28M
Stockholders' Equity $340.07M $347.67M $365.87M $365.87M $380.28M
Capital Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $0.00 $0.00 $0.00 $0.00 $0.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.04B $1.02B $1.01B $1.01B $991.95M
Retained Earnings -$700.06M -$673.20M -$641.56M -$641.56M -$611.71M
Gains/Losses Not Affecting Retained Earnings $22,000.00 -$19,000.00 $37,000.00 $37,000.00 $42,000.00
-Other Intangible Assets – – $709,000.00 $709,000.00 –
-Total Tax Payable – – $1.46M $1.46M –
Current Accrued Expenses – – $1.23M $1.23M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$19.25M -$38.13M -$48.99M -$10.33M -$6.64M
Net cash flow from continuing operations -$19.25M -$38.13M -$48.99M -$10.33M -$6.64M
Net Income from Continuing Operations -$26.86M -$31.64M -$95.57M -$29.85M -$21.41M
Gain/Loss from Continuing Operations $134,000.00 $297,000.00 $157,000.00 $278,000.00 $227,000.00
Depreciation & Depletion & Amortization $1.99M $1.74M $6.39M $1.71M $1.62M
Other Non-Cash Items -$159,000.00 -$159,000.00 -$508,000.00 -$127,000.00 -$127,000.00
Change in Working Capital -$9.73M -$21.90M -$7.84M $8.02M -$2.03M
-Change in Receivables -$11.63M -$13.32M -$898,000.00 $2.23M -$4.35M
-Change in Inventory $199,000.00 -$7.03M -$14.50M -$4.00M $568,000.00
-Change in Prepaid Assets $799,000.00 $1.17M -$1.10M -$431,000.00 -$1.76M
-Change in Payables and Accrued Expense -$839,000.00 -$3.10M $8.38M $7.36M $4.71M
-Change in Other Current Assets -$404,000.00 -$431,000.00 -$2.90M -$922,000.00 -$808,000.00
-Change in Other Current Liabilities $1.79M $180,000.00 -$132,000.00 $1.83M -$1.52M
-Change In Other Working Capital $356,000.00 $628,000.00 $3.31M $1.95M $1.13M
Net cash flow from investing -$2.95M -$2.91M -$9.36M -$1.85M -$2.87M
Net Cash Flow from Continuing Investing Activities -$2.95M -$2.91M -$9.36M -$1.85M -$2.87M
Net PPE Purchase and Sale -$2.95M -$2.91M -$9.36M -$1.85M -$2.87M
Financing Cash Flow $4.50M $222,000.00 $11.19M $4.44M $1.08M
Net Cash Flow from Continuing Financing Activities $4.50M $222,000.00 $11.19M $4.44M $1.08M
Proceeds from Stock Option Exercised $4.50M $222,000.00 $11.19M $4.44M $1.08M
Ending Cash Balance $230.95M $248.68M $289.54M $289.54M $297.32M
Net Change in Cash -$17.71M -$40.82M -$47.15M -$7.74M -$8.43M
Beginning Cash Balance $248.68M $289.54M $336.76M $297.32M $305.76M
Effect of Exchange Rate Changes -$20,000.00 -$42,000.00 -$74,000.00 -$41,000.00 -$10,000.00
Free Cash Flow -$22.20M -$41.04M -$58.34M -$12.18M -$9.50M
Net Common Stock Issuance – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on PRCT.

Leave a comment

Scroll to Top